News

Introducing LesionID Pro* with Automated Zero-Click Pre-Processing at SNMMI

Introducing LesionID Pro* with Automated Zero-Click Pre-Processing at SNMMI

A press release introducing an update of LesionID Pro* from MIM Software, a GE HealthCare Company.

June 21, 2025

Read the press release at gehealthcare.com.

*LesionID Pro with automated zero-click pre-processing is 510(k)-pending with the U.S. FDA. Not CE Marked and not licensed in accordance with Canadian law. Not available for sale in the United States, Europe, Canada, or any other region.
Theranostics Radiology and Nuclear Medicine Radiopharmaceutical Therapy Nuclear Medicine LesionID Pro
MIM Software

MIM Software

GE HealthCare’s MIM Software is a global provider of medical imaging analysis and artificial intelligence (AI) solutions for the practice of Radiation Oncology, Radiology & Nuclear Medicine, Theranostics, Diagnostic Imaging, and Urology at imaging centers, hospitals, specialty clinics, and research organizations worldwide.

Media Contact

Jim Janek

Marketing Director

MIM Software, a GE Healthcare Company

jim.janek@gehealthcare.com

440-212-4455

Read More

GE HealthCare’s MIM Software Announces FDA Clearance of Monte Carlo Dosimetry for Theranostics

October 9, 2024

A press release announcing that GE HealthCare’s MIM Software has received FDA clearance of a new Centiloid scaling tool in MIMneuro®.

GE HealthCare's MIM Software Announces FDA Clearance of New Centiloid Scaling Tool to Quantify Amyloid Plaque in Brain Imaging

September 17, 2024

A press release announcing that GE HealthCare’s MIM Software has received FDA clearance of a new Centiloid scaling tool in MIMneuro®.

MIM Software Is a 2024 NorthCoast 99 Award Winner

August 23, 2024

MIM Software has been recognized as one of 99 great Northeast Ohio workplaces for top talent. Read about what makes MIM an award-winning workplace.

Send Me More Information Arrow